The product label and all related promotional materials for Simparica Trio have always included information about neurologic signs such as tremors, unsteadiness, and/or seizures that have been ...

Simparica Trio also contains moxidectin and pyrantel. ... These uses are “extra-label” or “off-label,” meaning that there is evidence of safe and effective use, ...

Zoetis expects to launch Simparica Trio in the EU in the first quarter of 2020. The approval should strengthen the company’s market-leading parasiticide portfolio for companion animals.